| Literature DB >> 23619945 |
Yingtai Chen1, Tongzhang Zheng, Qing Lan, Christopher Kim, Qin Qin, Francine Foss, Xuezhong Chen, Theodore Holford, Brian Leaderer, Peter Boyle, Chengfeng Wang, Min Dai, Zhenjiang Liu, Shuangge Ma, Stephen J Chanock, Nathaniel Rothman, Yawei Zhang.
Abstract
We conducted a population-based case-control study in Connecticut women to test the hypothesis that genetic variations in DNA repair pathway genes may modify the relationship between body mass index (BMI) and risk of non-Hodgkin lymphoma (NHL). Compared to those with BMI <25, women with BMI ≥25 had significantly increased risk of NHL among women who carried BRCA1 (rs799917) CT/TT, ERCC2 (rs13181) AA, XRCC1 (rs1799782) CC, and WRN (rs1801195) GG genotypes, but no increase in NHL risk among women who carried BRCA1 CC, ERCC2 AC/CC, XRCC1 CT/TT, and WRN GT/TT genotypes. A significant interaction with BMI was only observed for WRN (rs1801195; P = 0.004) for T-cell lymphoma and ERCC2 (rs13181; P = 0.002) for diffuse large B-cell lymphoma. The results suggest that common genetic variation in DNA repair pathway genes may modify the association between BMI and NHL risk.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23619945 PMCID: PMC3902049 DOI: 10.1002/ajh.23463
Source DB: PubMed Journal: Am J Hematol ISSN: 0361-8609 Impact factor: 10.047